Cynvenio, St. Luke's Partner on Breast Cancer Study

genomeweb
360dx

Cynvenio, St. Luke's Partner on Breast Cancer Study

Aug 17, 2017

NEW YORK (GenomeWeb) – Cynvenio Biosystems today announced the launch of a breast cancer monitoring study in partnership with Saint Luke's Cancer Institute.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants
Cancer Increase Reported in Families With Tau Mutation-Associated Neurodegeneration
Precipio Inks Distribution Deal With Italy's Euroclone Diagnostica
Merck, Foundation Medicine to Develop Companion Diagnostics for Immunotherapy
Mobidiag Concludes €4M Funding Round
Agendia Inks Southeast Asian Marketing Deal for Breast Cancer Tests

The Scan

Make Sense of It All

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

Variations on Results

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

This Week in Nature

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

Of Many Minds

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Main menu